Dong W Choi
Overview
Explore the profile of Dong W Choi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim H, Jung W, Shin Y, Han I, Byun Y, Lee H, et al.
HPB (Oxford)
. 2021 May;
23(10):1623-1628.
PMID: 34001453
Background: Intraductal papillary mucinous neoplasm (IPMN) is an broad-spectrum disease from benign to malignant. Inflammatory markers are known as prognostic predictors in various diseases. The purpose of this study was...
2.
Ryu Y, Shin S, Kim J, Jeong W, Park D, Kim N, et al.
HPB (Oxford)
. 2020 May;
22(12):1782-1792.
PMID: 32354655
Background: Recently, several studies have reported that sarcopenia and sarcopenic obesity (SO) could worsen postoperative complications after PD. This study aims to evaluate the effects of preoperative sarcopenia and SO...
3.
Han S, Choi S, Choi D, Heo J, Han I, Park D, et al.
Minerva Chir
. 2019 May;
75(1):15-24.
PMID: 31115240
Background: Neoadjuvant therapy is recommended for patients with borderline-resectable pancreatic cancer (BRPC). In this study, we compare survival outcomes of neoadjuvant therapy with upfront surgery. Methods: From January 2011 to...
4.
You Y, Han I, Choi D, Heo J, Ryu Y, Park D, et al.
HPB (Oxford)
. 2019 Apr;
21(11):1436-1445.
PMID: 30982739
Background: Previous studies analyzed risk factors for postoperative pancreatic fistula (POPF) and developed risk prediction tool using scoring system. However, no study has built a nomogram based on individual risk...
5.
Jeong J, Choi D, Choi S, Heo J, Jang K
ANZ J Surg
. 2014 Mar;
85(4):264-9.
PMID: 24641800
Background: The purpose of this study was to clarify the post-operative prognosis of pancreatic head cancer with pathologic portal vein (PV) or superior mesenteric vein (SMV) invasion. Methods: From May...
6.
Bandow N, Gilles V, Freesmeier B, Semrau J, Krentz B, Gallagher W, et al.
J Inorg Biochem
. 2012 Apr;
110:72-82.
PMID: 22504273
Methanobactin (mb) is the first characterized example of a chalkophore, a class of copper-binding chromopeptides similar to iron-binding siderophores. Structural, redox, themodynamic, and spectral studies on chalkophores have focused almost...
7.
Bandow N, Gallagher W, Behling L, Choi D, Semrau J, Hartsel S, et al.
Methods Enzymol
. 2011 Mar;
495:259-69.
PMID: 21419927
Chalkophores are low molecular mass modified peptides involved in copper acquisition in methane-oxidizing bacteria (MOB). A screening method for the detection of this copper-binding molecule is presented in Chapter 16....
8.
Choi D, Bandow N, McEllistrem M, Semrau J, Antholine W, Hartsel S, et al.
J Inorg Biochem
. 2010 Sep;
104(12):1240-7.
PMID: 20817303
Methanobactin (mb) is a low molecular mass copper-binding molecule analogous to iron-binding siderophores. The molecule is produced by many methanotrophic or methane oxidizing bacteria (MOB), but has only been characterized...
9.
Behling L, Hartsel S, Lewis D, DiSpirito A, Choi D, Masterson L, et al.
J Am Chem Soc
. 2008 Aug;
130(38):12604-5.
PMID: 18729522
Methanobactin (mb) is a small copper-binding peptide produced by methanotrophic bacteria and is intimately involved in both their copper metabolism and their role in the global carbon cycle. The structure...
10.
Choi D, Semrau J, Antholine W, Hartsel S, Anderson R, Carey J, et al.
J Inorg Biochem
. 2008 Mar;
102(8):1571-80.
PMID: 18372044
Methanobactin (mb) is a copper-binding chromopeptide that appears to be involved in oxidation of methane by the membrane-associated or particulate methane monooxygenase (pMMO). To examine this potential physiological role, the...